Suppr超能文献

增殖刺激活性(MSA)对人胎儿及产后软骨的体外作用。

In vitro effect of multiplication stimulating activity (MSA) on human fetal and postnatal cartilage.

作者信息

Ashton I K, Otremski I

出版信息

Early Hum Dev. 1986 Apr;13(2):161-7. doi: 10.1016/0378-3782(86)90004-6.

Abstract

Although insulin-like growth factors may have a physiological role in fetal growth, little is known of their biological action on human fetal tissues. In the present study, the action of multiplication stimulating activity (MSA) on human fetal cartilage in vitro, has been examined and compared with its effect on postnatal cartilage. Addition of MSA (10-100 ng/ml) resulted in a dose dependent increase in [3H]thymidine incorporation into fetal cartilage aged between 15 and 18 weeks of gestation. The mean response with 100 ng/ml was 143 +/- 18% (n = 10) of basal levels. The increase in [35S]sulphate incorporation was variable, the mean (131 +/- 36%, n = 5) being not significantly greater than in controls. The increase in [3H]thymidine incorporation on addition of MSA was not seen in fetal cartilage of earlier (13/14 wk) or later (19 wk) gestational age. MSA-III (a highly purified component of MSA) at 100 ng/ml increased [3H]thymidine and [35S]sulphate incorporation into cartilage from a fetus of 17 weeks to 165% and 150%, respectively, but had no effect on the incorporation of either isotope into cartilage from a fetus of 19 weeks gestation. In contrast to the mitogenic effects of MSA on fetal cartilage, the same preparation had no effect on either [3H]thymidine or [35S]sulphate incorporation into postnatal cartilage. These results may reflect developmental changes in cartilage response to insulin-like growth factors similar to those reported in human brain.

摘要

尽管胰岛素样生长因子可能在胎儿生长中具有生理作用,但对其在人类胎儿组织上的生物学作用却知之甚少。在本研究中,已对增殖刺激活性(MSA)在体外对人类胎儿软骨的作用进行了检测,并与它对出生后软骨的作用进行了比较。添加MSA(10 - 100纳克/毫升)导致妊娠15至18周的胎儿软骨中[3H]胸苷掺入量呈剂量依赖性增加。100纳克/毫升时的平均反应为基础水平的143±18%(n = 10)。[35S]硫酸盐掺入量的增加则有所不同,平均增加量(131±36%,n = 5)并不显著高于对照组。在妊娠早期(13/14周)或晚期(19周)的胎儿软骨中,添加MSA后未见[3H]胸苷掺入量增加。100纳克/毫升的MSA-III(MSA的一种高度纯化成分)使17周胎儿的软骨中[3H]胸苷和[35S]硫酸盐掺入量分别增加到165%和150%,但对妊娠19周胎儿的软骨中这两种同位素的掺入均无影响。与MSA对胎儿软骨的促有丝分裂作用相反,相同制剂对出生后软骨中[3H]胸苷或[35S]硫酸盐的掺入均无影响。这些结果可能反映了软骨对胰岛素样生长因子反应的发育变化,类似于在人类大脑中所报道的情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验